Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Benzthiazide measurement (procedure) |
Has measured component |
False |
Benzthiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzthiazide measurement (procedure) |
Component |
True |
Benzthiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Benzthiazide 25 mg and triamterene 50 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzthiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely chlortalidone 50 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzthiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing benzthiazide and triamterene (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzthiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Benzthiazide-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzthiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Poisoning caused by benzothiadiazide |
Causative agent (attribute) |
False |
Benzthiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Benzthiazide 25 mg and triamterene 50 mg oral capsule |
Has basis of strength substance (attribute) |
True |
Benzthiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Benzthiazide 25 mg and triamterene 50 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Benzthiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Benzthiazide 25 mg and triamterene 50 mg oral capsule |
Has basis of strength substance (attribute) |
False |
Benzthiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Benzthiazide 25 mg and triamterene 50 mg oral capsule |
Has precise active ingredient |
True |
Benzthiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing benzthiazide and triamterene in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzthiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Benzthiazide and triamterene only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzthiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Benzthiazide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzthiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Benzthiazide and triamterene only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Benzthiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely benzthiazide 25 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Benzthiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely benzthiazide 25 milligram and triamterene 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Benzthiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |